Company: BGLC
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001477932-25-002725
Chunk: 68

Company: BioNexus Gene Lab Corp
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1C
Chunk 68
---
 

 F-20Table of Contents

BIONEXUS GENE LAB CORP. 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 

FOR THE YEAR ENDED DECEMBER 31, 2024 AND 2023

(Currency expressed in United States Dollars (“US$”)) 

(Audited)

NOTE 6 – PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment consisted of the following:   As of   December 31,  December 31,   2024  2023        Air conditioner  $1,124  $1,124 Computer and software  5,880   3,923 Equipment  65,214   60,412 Furniture and fittings  98,883   100,118 Lab equipment  320,102   320,102 Land and buildings   1,506,969   1,506,969 Motor vehicle  161,148   161,148 Office equipment  37,604   33,914 Renovation  101,137   98,597 Signboard  806   806 Solar PV System  16,935   - Machinery   190,341   - *Capital Work In Progress  -   109,509    2,506,143   2,396,622 (Less): Accumulated depreciation  (756,976)  (659,115)(Less): Accumulated impairment  (40,173)   - Add: Foreign translation differences  (186,004)  (225,889)Property, plant and equipment, net $1,522,990  $1,511,618   During the year ended December 31, 2024 and 2023, the Company recorded depreciation of $104,160 and $83,253, respectively. *includes an amount of $109,509 as explained in Note 14

 F-21Table of Contents

BIONEXUS GENE LAB CORP. 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 

FOR THE YEAR ENDED DECEMBER 31, 2024 AND 2023 

(Currency expressed in United States Dollars (“US$”)) 

(Audited) 

NOTE 7 – INVEST